CERUS CORP Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
CERUS CORP (CERS) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of -$56.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-03-02
- CERUS CORP effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was -$56.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2025-12-31 | -$56.00K 10-K · filed 2026-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |